Privacy and safety

Patient consent for AI scribes in Ontario

Consent for an AI scribe is distinct from consent to treatment. A patient should receive understandable information about the technology's purpose, information handling, material risks, clinician review, available alternative, and ability to withhold or withdraw consent without losing care.

Reading time
3 minutes
Updated
02

Explain what a reasonable patient would want to know

Avoid describing the tool as merely “taking notes” if it records, transcribes, summarizes, stores, or sends information to a vendor. The explanation should reflect the actual configured data flow.

  • That an AI-assisted documentation tool will capture or process the encounter.
  • The purpose: for example, producing a draft note for clinician review.
  • What information is involved and which external service providers receive it.
  • Material benefits and limitations, including errors, omissions, bias, and privacy risk.
  • That the clinician reviews and remains accountable for the final documentation.
  • How long relevant information is kept under the practice's approved setup.
  • That the patient may ask questions, refuse, or withdraw consent and use an alternative.
03

Document the process proportionately

The practice should decide what its record needs to show: who consented, the method, date or encounter, the purpose explained, any limits, and whether a substitute decision-maker was involved. A product checkbox can support this process but cannot replace the underlying conversation.

Use an approved script or patient notice to improve consistency, then allow questions. When the use changes, such as a new purpose, vendor, participant, or data practice, assess whether new notice or consent is needed.

04

Handle refusal and withdrawal respectfully

A person who withholds consent should continue to receive the same or a similar level of care through an alternative documentation method. Staff should know that path before the visit starts so refusal does not create pressure or delay.

If consent is withdrawn after capture begins, stop further collection through the AI scribe. Follow the approved process for information already collected and explain the next steps. The response may depend on PHIPA, the practice's obligations, the technical state, and the record context.

05

Plan for situations that need more care

  • Capacity and substitute decision-makers.
  • Minors and profession-specific consent rules.
  • Interpreters, family members, learners, or multiple participants.
  • Virtual visits and people joining after capture begins.
  • Sensitive services or settings where the risk profile is different.
  • A participant who consents initially but later objects.

Sources and further reading

Sources were checked on . External guidance can change; open the source before relying on it.

  1. AI Scribes: Key Considerations for the Health SectorInformation and Privacy Commissioner of Ontario
  2. Consent and your personal health informationInformation and Privacy Commissioner of Ontario
  3. AI Scribes: Answers to frequently asked questionsCanadian Medical Protective Association

Next

How consent works before encounter capture in PorvioUnderstand Porvio's consent checkpoint, what it records, and what Ontario practices still need to decide before using AI-assisted encounter capture.3 minAI-assisted clinical documentation in Ontario: an adoption guideA practical guide to evaluating and introducing an AI scribe or documentation assistant in an Ontario healthcare practice.3 minPHIPA and clinical AI vendors: questions Ontario practices should askA PHIPA-focused due-diligence checklist for Ontario practices evaluating an AI scribe or clinical documentation vendor.3 min

Ready to see the workflow?

Keep consent, review, and follow-through in one place.

Create workspace Review plans